Overview of the Attempted Acquisition
Acquirer: UnitedHealth Group (via its subsidiary, Optum)
Target: Amedisys Inc.
Proposed Transaction Size: $3.3 billion
Offer Details: $101 per share in cash
Initial Announcement Date: June 26, 2023
Current Status: Pending, with legal challenges from the U.S. Department of Justice (DOJ)
Target Advisors: Not publicly disclosed
Acquirer Advisors: Not publicly disclosed
On June 26, 2023, UnitedHealth Group, through its subsidiary Optum, announced a definitive agreement to acquire Amedisys Inc., a leading provider of home health and hospice services, for approximately $3.3 billion. The offer of $101 per share in cash represented a 26% premium over Amedisys’ most recent closing share price at that time.
Company Details (Acquirer – UnitedHealth Group)
UnitedHealth Group is a diversified healthcare company offering a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, providing healthcare coverage and benefits services, and Optum, delivering information and technology-enabled health services.
- Founded: 1977
- Headquarters: Minnetonka, Minnesota, USA
- CEO: Andrew Witty
- 2024 Revenue: Approximately $400 billion
- Market Cap: Over $500 billion
- Recent Acquisitions:
- LHC Group (2023)
- Change Healthcare (2022)
Company Details (Target – Amedisys Inc.)
Amedisys Inc. is a leading provider of home health, hospice, and personal care services, operating across the United States.
- Founded: 1982
- Headquarters: Baton Rouge, Louisiana, USA
- CEO: Paul Kusserow
- 2024 Revenue: Approximately $2.2 billion
- Employees: Over 21,000
- Services:
- Home Health Care
- Hospice Care
- Personal Care Services
Projections and Assumptions
Short-Term Consequences
- Regulatory Challenges: In November 2024, the DOJ, along with attorneys general from Maryland, Illinois, New Jersey, and New York, filed a lawsuit to block the acquisition, citing concerns that the merger would substantially lessen competition in the home health and hospice markets, potentially leading to higher costs and reduced quality of care.
- Legal Proceedings: In response to the DOJ’s lawsuit, UnitedHealth Group and Amedisys filed a motion in December 2024 to dismiss the case, arguing that the government failed to define specific geographic regions where the deal would stifle competition.
Long-Term Upsides
- Enhanced Service Offerings: If approved, the acquisition would allow UnitedHealth Group to expand its home health and hospice services, building upon its previous $5.4 billion acquisition of LHC Group in 2023.
- Integrated Care Delivery: The merger could facilitate a more integrated approach to patient care, leveraging Optum’s capabilities in data analytics and care coordination to improve outcomes for patients receiving home-based services.
Risks and Uncertainties
- Antitrust Concerns: The DOJ’s lawsuit highlights significant antitrust concerns, suggesting that the merger could reduce competition, negatively affecting consumers and healthcare workers.
- Deal Uncertainty: The legal challenges introduce uncertainty regarding the completion of the acquisition, with the extended deadline for closing now set for December 31, 2025, or 10 days after a final court ruling, whichever comes first.
Sources
